Particle.news

Download on the App Store

Grasim to tap Rs 1,000 crore bond market as HCL partners with UiPath and Biocon wins diabetes drug clearance

Investor demand for corporate funding has surged following strategic partnerships, product clearances, landmark debt issuances

Image
Top stocks in news: Prostarm, Zinka, Aptus Value, YES Bank, HCL Tech, ITC, YES Bank, Adani stocks
Image
Image

Overview

  • Grasim Industries’ Finance Committee approved issuance of up to Rs 1,000 crore in non-convertible debentures priced at Rs 100,000 apiece to tap debt markets.
  • HCL Technologies entered into a global collaboration with UiPath to deploy agentic automation solutions and plans to establish an AI laboratory in India.
  • Biocon secured Indian regulatory approval for its biosimilar version of Liraglutide for Type 2 diabetes in pre-filled pens and cartridges.
  • Torrent Power signed a long-term LNG supply pact with BP Singapore to receive up to 0.41 million tonnes per annum from 2027 through 2036.
  • UGRO Capital green-lighted a rights issue to raise up to Rs 400 crore at Rs 162 per share and MAN Industries outlined a plan to mobilize Rs 300 crore via promoter convertible warrants and fresh equity shares.